Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Safety Alerts

Ondansetron: Birth defects

Overview Ondansetron is a 5-HT3 receptor antagonist indicated for the treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. It is also indicated for prevention and…

Safety Alerts

New safety measure for sodium valproate: (i) Risk of congenital malformation in neonates and neurodevelopmental problems in children exposed to sodium valproate during pregnancy; (ii) Additional educational material for healthcare professionals and patien

Further information related to this safety issue has become available. Readers are advised to also refer to the NPRA Safety Alert on Valproate (Sodium Valproate, Valproic Acid): Potential Risks to…

Document attached

Announcement - Generic

HSA-NPRA Generic Medicines Work Sharing Initiative

The HSA-NPRA Generic Medicines Work Sharing Initiative is a work sharing model for the joint collaborative assessment of a generic medicine registration application filed with both the Health…

Document attached